Literature DB >> 6684797

Regulation of glucose 6-phosphate dehydrogenase expression in CHO-human fibroblast somatic cell hybrids.

M D'Urso, C Mareni, D Toniolo, M Piscopo, D Schlessinger, L Luzzatto.   

Abstract

Human--hamster somatic cell hybrids have been obtained by fusion of a CHO line (NA31) doubly deficient in hypoxanthine guanine phosphoribosyltransferase and glucose 6-phosphate dehydrogenase (G6PD) with normal G6PD(+) human fibroblasts. Analysis of NA31 extracts has revealed that, although G6PD activity is nearly absent, significant activity can be detected with 2-deoxyglucose 6-phosphate as substrate, so that the mutant and normal forms of the enzyme can both be easily detected. The cell hybrids obtained express human G6PD. The human G6PD subunits are distributed in homodimeric molecules as well as in human--hamster heterodimeric molecules. However, whereas the amount of hamster G6PD subunits present in the hybrid is similar to that in the hamster parental cells, the amount of human G6PD subunits is decreased by 3- to 10-fold when compared to the human parental cell. These results indicate that either the expression of the G6PD gene or the stability of the gene product is altered in the hybrid. By mutagenesis and selection in diamide (a substance that oxidizes intracellular glutathione), we have isolated a clone with a 3- to 5-fold increase in human G6PD activity. This derivative may have an increased rate of expression of the human G6PD structural gene.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6684797     DOI: 10.1007/bf01543044

Source DB:  PubMed          Journal:  Somatic Cell Genet        ISSN: 0098-0366


  8 in total

1.  Stable integration and expression in mouse cells of yeast artificial chromosomes harboring human genes.

Authors:  B Eliceiri; T Labella; Y Hagino; A Srivastava; D Schlessinger; G Pilia; G Palmieri; M D'Urso
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

Review 2.  The role of NURR1 in metabolic abnormalities of Parkinson's disease.

Authors:  Murad Al-Nusaif; Yuting Yang; Song Li; Cheng Cheng; Weidong Le
Journal:  Mol Neurodegener       Date:  2022-06-27       Impact factor: 18.879

3.  Tissue-specific levels of human glucose-6-phosphate dehydrogenase correlate with methylation of specific sites at the 3' end of the gene.

Authors:  G Battistuzzi; M D'Urso; D Toniolo; G M Persico; L Luzzatto
Journal:  Proc Natl Acad Sci U S A       Date:  1985-03       Impact factor: 11.205

4.  Physical mapping of new DNA probes near the fragile X mutation (FRAXA) by using a panel of cell lines.

Authors:  G K Suthers; V J Hyland; D F Callen; I Oberle; M Rocchi; N S Thomas; C P Morris; C E Schwartz; M Schmidt; H H Ropers
Journal:  Am J Hum Genet       Date:  1990-08       Impact factor: 11.025

5.  Identification of novel RFLPs in the vicinity of CpG islands in Xq28: application to the analysis of the pattern of X chromosome inactivation.

Authors:  E Maestrini; S Rivella; C Tribioli; M Rocchi; G Camerino; S Santachiara-Benerecetti; O Parolini; L D Notarangelo; D Toniolo
Journal:  Am J Hum Genet       Date:  1992-01       Impact factor: 11.025

6.  Failure to increase glucose consumption through the pentose-phosphate pathway results in the death of glucose-6-phosphate dehydrogenase gene-deleted mouse embryonic stem cells subjected to oxidative stress.

Authors:  Stefania Filosa; Annalisa Fico; Francesca Paglialunga; Marco Balestrieri; Almudena Crooke; Pasquale Verde; Paolo Abrescia; José M Bautista; Giuseppe Martini
Journal:  Biochem J       Date:  2003-03-15       Impact factor: 3.857

7.  The pentose phosphate pathway regulates chronic neuroinflammation and dopaminergic neurodegeneration.

Authors:  Dezhen Tu; Yun Gao; Ru Yang; Tian Guan; Jau-Shyong Hong; Hui-Ming Gao
Journal:  J Neuroinflammation       Date:  2019-12-05       Impact factor: 8.322

8.  Targeted disruption of the housekeeping gene encoding glucose 6-phosphate dehydrogenase (G6PD): G6PD is dispensable for pentose synthesis but essential for defense against oxidative stress.

Authors:  P P Pandolfi; F Sonati; R Rivi; P Mason; F Grosveld; L Luzzatto
Journal:  EMBO J       Date:  1995-11-01       Impact factor: 11.598

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.